Update - Zayed National Museum and Bahrain Launch Six-Week Archaeologica… Transport - Dubai RTA Introduces Five-Star Rating System for Taxi Companies… Weather - Rain Expected in Some Areas on November 16 as Temperatures Drop…

Send an Inquiry

Fill in the details below and our team will get back to you.

Business 1 min read 64 views

Julphar-MSD Partnership Recognized with Top US Award

One of the largest pharmaceutical manufacturers in the Middle East and Africa, has won the distinguished Organization of Strategic Alliance Professionals (ASAP) award for 2018 together with its partnership partner, MSD.

This is the first time a pharmaceutical company from the Middle East and Africa has won
the award It does highlight the contributions both companies are supplying in alliance administration to assist develop a stronger value suggestion for the local patients and the healthcare community.

Jerome Carle, General Manager of Julphar, said, "Winning the prestigious ASAP award
is a confirmation that the world is paying attention to the essential contribution Julphar is making to the global healthcare market. We take terrific satisfaction in our partnership with MSD and with each other we bring value and top quality to the healthcare community.

" MSD is a global leader and with our partnership, we have the ability to go beyond expectations, develop and make best-in- course solutions to assist meet individuals' demands and make a difference to family members in the region. We're truly recognized to be recognized for this award." MSD (called Merck & Co in the US and Canada) is a global doctor and one of the biggest pharmaceutical companies on the planet. Julphar authorized a five-year licensing take care of the company in 2014, providing it special civil liberties to produce, market, disperse and sell certain MSD medicines in the UAE, Kuwait, Bahrain, Oman, Qatar and Iraq.

Mazen Altaruti, AVP & Managing Director for MSD in the GCC, said, "This award represents a fantastic success for the region in terms of alliances and collaborations on a local and global range. Obtaining this award highlights the vital job being carried out in the health care industry by both firms to assure access to medicines for people. We look forward to your continued partnership and effective impact in 2018 and beyond."

The 2018 ASAP honors finalists were selected for their outstanding leadership and payments and completed in 4 different groups: Alliance for Corporate Social Duty, Alliance Program Excellence, Individual Alliance Excellence, and Innovative Best Alliance Practice.

Victors were revealed at a honors event at the 2018 ASAP Global Partnership Summit, "Propelling Partnering for the On-Demand World: New Perspectives + Proven Practices for Collaborative Business," which was held from 26-28 March in Ft Lauderdale, Florida, U.S.A.

Last month, Julphar announced it had been placed top pharmaceutical company in the UAE by IMS Health February 2018 panel, reflecting a strong dual number sales development versus 2017.

About Julphar
Julphar is one of the biggest pharmaceutical manufacturers Middle East and Africa and for practically four years, the company has been supplying excellent quality, innovative and affordable healthcare services to families around the world. Established under the advice of His Highness Sheikh Saqr Bin Mohammed Al Qasimi in 1980, Julphar employs greater than 5,000 individuals and disperses pharmaceutical products to greater than 50 countries on 5 continents.

Julphar's business is centered on 3 core business units - Julphar Diabetic issues Solutions, General Medicines and its consumer division, Julphar Life-- which target major healing sections consisting of Gastrology, Discomfort Administration, Wound Care, Antibiotics and Cardio-metabolism.

Julphar has 16 globally accredited facilities in Africa, Middle East and Asia that generate more than a million boxes of medications a day. In 2012, Julphar turned into one of the biggest producer of Insulin with its UAE-based Biotechnology production unit based.

To find out more, go to http://www.julphar.net

About MSD
For greater than a century, MSD, a leading global biopharmaceutical company, has been designing permanently, bringing forward medications and injections for the world's mostdifficult illness. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. Via our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 nations to deliver innovative health options. We likewise demonstrate our commitment to enhancing access to healthcare with far-ranging plans, programs and collaborations.
Today, MSD remains to be at the leading edge of research to progress the prevention and therapy of conditions that endanger people and communities worldwide - including cancer, cardio-metabolic illness, emerging animal illness, Alzheimer's disease and transmittable conditions consisting of HIV and Ebola.

Related News

More on Business

View all

Comments (0)

Join the conversation

No comments yet. Be the first to share your thoughts!

More News

See all
Business

Big 5 Global 2026: Six French companies to showcase advanced construction technologies in Dubai

Six French companies will present their construction technologies and expertise at Big 5 Global 2026, scheduled to take place from November 23 to 26 at the Dubai World Trade Centre. Supported by Business France, AITENDERS, ALPHI ME, ARIADIS, COMUS, CSTB and QUADRA will showcase solutions across...

Nov 16, 2026 · 3 min
Education

JICE connects UAE students with higher education opportunities in Japan at NAJAH Abu Dhabi 2026

The Japan International Cooperation Center (JICE) welcomed approximately 1,200 visitors to the Japan Pavilion at NAJAH Abu Dhabi 2026, held from October 18 to 21 at ADNEC Centre Abu Dhabi. The initiative introduced students and families to higher education opportunities in Japan through...

Nov 16, 2026 · 2 min
Real Estate

Emirates REIT reports 12% rise in property income as Funds from Operations nearly double in Q3 2026

Emirates REIT (CEIC) PLC reported strong financial results for the nine months ended September 30, 2026, with year-on-year growth in property income, operating profit and Funds from Operations (FFO), alongside improvements in its balance sheet. Equitativa (Dubai) Limited, the manager of Emirates...

Nov 16, 2026 · 2 min
Education

Almasar Alshamil Education outlines vision for future of learning at Education Investment MENA 2026

Almasar Alshamil Education Chief Executive Officer Majed Al Mutairi joined regional education leaders at Education Investment MENA 2026 in Dubai, where discussions focused on the future of learning, the role of technology and the importance of collaboration across the education sector. Held on...

Nov 16, 2026 · 2 min
Trusted by

Our Associates

Brands and organisations that work with Day of Dubai.